Literature DB >> 15322202

Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10.

Martin J Raftery1, Dörte Wieland, Stefanie Gronewald, Annette A Kraus, Thomas Giese, Günther Schönrich.   

Abstract

Human dendritic cells (DCs) are essential for the antiviral immune response and represent a strategically important target for immune evasion of viruses, including human CMV (HCMV). Recently, HCMV has been discovered to encode a unique IL-10 homologue (cmvIL-10). In this study we investigated the capacity of cmvIL-10 to shape phenotype, function, and survival of DCs. For comparison we included human IL-10 and another IL-10 homologue encoded by EBV, which does not directly target DCs. Interestingly, cmvIL-10 strongly activated STAT3 in immature DCs despite its low sequence identity with human IL-10. For most molecules cmvIL-10 blocked LPS-induced surface up-regulation, confirming its role as an inhibitor of maturation. However, a small number of molecules on LPS-treated DCs including IDO, a proposed tolerogenic molecule, showed a different behavior and were up-regulated in response to cmvIL-10. Intriguingly, the expression of C-type lectin DC-specific ICAM-grabbing nonintegrin, a receptor for HCMV infection found exclusively on DCs, was also enhanced by cmvIL-10. This phenotypic change was mirrored by the efficiency of HCMV infection. Moreover, DCs stimulated with LPS and simultaneously treated with cmvIL-10 retained the function of immature DCs. Finally, cmvIL-10 increased apoptosis associated with DC maturation by blocking up-regulation of the antiapoptotic long form cellular FLIP. Taken together, these findings show potential mechanisms by which cmvIL-10 could assist HCMV to infect DCs and to impair DC function and survival.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322202     DOI: 10.4049/jimmunol.173.5.3383

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

Review 1.  Fighting cancer with oncolytic viruses.

Authors:  Yuti Chernajovsky; Lorna Layward; Nicholas Lemoine
Journal:  BMJ       Date:  2006-01-21

Review 2.  Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.

Authors:  Barry Slobedman; Peter A Barry; Juliet V Spencer; Selmir Avdic; Allison Abendroth
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

Review 3.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

Review 4.  Cytomegalovirus immune evasion of myeloid lineage cells.

Authors:  Melanie M Brinkmann; Franziska Dağ; Hartmut Hengel; Martin Messerle; Ulrich Kalinke; Luka Čičin-Šain
Journal:  Med Microbiol Immunol       Date:  2015-03-17       Impact factor: 3.402

Review 5.  Herpesvirus-bacteria synergistic interaction in periodontitis.

Authors:  Casey Chen; Pinghui Feng; Jørgen Slots
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

6.  Novel understanding of self-reactive T cells.

Authors:  Mads Hald Andersen
Journal:  Oncoimmunology       Date:  2015-08-31       Impact factor: 8.110

Review 7.  Dendritic cells in viral pathogenesis: protective or defective?

Authors:  Gabriele Pollara; Antonia Kwan; Philippa J Newton; Matthew E Handley; Benjamin M Chain; David R Katz
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

Review 8.  Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.

Authors:  Hunter K Roark; Jennifer A Jenks; Sallie R Permar; Mark R Schleiss
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

9.  Inhibition of CD1 antigen presentation by human cytomegalovirus.

Authors:  Martin J Raftery; Manuel Hitzler; Florian Winau; Thomas Giese; Bodo Plachter; Stefan H E Kaufmann; Günther Schönrich
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

10.  Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.

Authors:  C Jenkins; W Garcia; M J Godwin; J V Spencer; J Lewis Stern; A Abendroth; B Slobedman
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.